David Young, Chief Scientific Officer at QUESTCOR PHARMACEUTICALS INC (QCOR), sold 6,000 shares at $91.96 ($552K) on 2014-06-24, disclosed to the SEC on 2014-06-26.
Scheduled sale ($552k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCSA | BUY | 2026-06-01 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-19 | $5K | — | Filing → |
| PCSA | BUY | 2026-05-01 | $5K | — | Filing → |